CYP2E1 and metabolic dysfunction-associated steatotic liver disease: It is still unclear why CYP2E1 activity is increased in obesity and NAFLD, even though some studies suggested the role of disturbed intra-hepatic insulin signalling and/or accumulation of some endogenous derivatives such as ketone bodies and saturated fatty acids [18,20,24].